Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine infusion during laparoscopic bariatric surgery
ChiCTR2200060618Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in obesity (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Quality of recovery on postoperative day 1. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200060618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060618.